Browse by ORCID

Group by: Item Type | No Grouping
Number of items: 6.

Journal article

DI MODUGNO, F., DI CARLO, A., SPADA, S., PALERMO, B., D'AMBROSIO, L., D'ANDREA, D., MORELLO, G., BELMONTE, B., SPERDUTI, I., BALZANO, V., GALLO, E., MELCHIONNA, R., PANETTA, M., CAMPO, G., DE NICOLA, F., GOEMAN, F., ANTONIANI, B., CARPANO, S., FRIGÈ, G., WARREN, S., GALLINA, F., LAMBRECHTS, D., XIONG, J., VINCENT, B.G., WHEELER, N., BORTONE, D.S., CAPPUZZO, F., FACCIOLO, F., TRIPODO, C., VISCA, P. and NISTICÒ, P., 2024. Tumoral and stromal hMENA isoforms impact tertiary lymphoid structure localization in lung cancer and predict immune checkpoint blockade response in patients with cancer. eBioMedicine, 101: 105003. ISSN 2352-3964

HATZIAPOSTOLOU, M., KOUTSIOUMPA, M., ZAITOUN, A.M., POLYTARCHOU, C., EDDERKAOUI, M., MAHURKAR-JOSHI, S., VADAKEKOLATHU, J., D'ANDREA, D., LAY, A.R., CHRISTODOULOU, N., PHAM, T., YAU, T.-O., VORVIS, C., CHATTERJI, S., PANDOL, S.J., POULTSIDES, G.A., DAWSON, D.W., LOBO, D.N. and ILIOPOULOS, D., 2024. Promoter methylation leads to Hepatocyte Nuclear Factor 4A loss and pancreatic cancer aggressiveness. Gastro Hep Advances, 3 (5), pp. 687-702. ISSN 2772-5723

PALERMO, B., FRANZESE, O., FRISULLO, G., D’AMBROSIO, L., PANETTA, M., CAMPO, G., D’ANDREA, D., SPERDUTI, I., DE NICOLA, F., GOEMAN, F., GALLINA, F., VISCA, P., FACCIOLO, F. and NISTICÒ, P., 2023. CD28/PD1 co-expression: dual impact on CD8+ T cells in peripheral blood and tumor tissue, and its significance in NSCLC patients' survival and ICB response. Journal of Experimental and Clinical Cancer Research, 42 (1). ISSN 1756-9966

TRONO, P., TOCCI, A., PALERMO, B., DI CARLO, A., D'AMBROSIO, L., D'ANDREA, D., DI MODUGNO, F., DE NICOLA, F., GOEMAN, F., CORLEONE, G., WARREN, S., PAOLINI, F., PANETTA, M., SPERDUTI, I., BALDARI, S., VISCA, P., CARPANO, S., CAPPUZZO, F., RUSSO, V., TRIPODO, C., ZUCALI, P., GREGORC, V., MARCHESI, F. and NISTICO, P., 2023. hMENA isoforms regulate cancer intrinsic type I IFN signaling and extrinsic mechanisms of resistance to immune checkpoint blockade in NSCLC. Journal for ImmunoTherapy of Cancer, 11 (8): e006913. ISSN 2051-1426

TURCO, E.M., GIOVENALE, A.M.G., SIRENO, L., MAZZONI, M., CAMMARERI, A., MARCHIORETTI, C., GORACCI, L., DI VEROLI, A., MARCHESAN, E., D’ANDREA, D., FALCONIERI, A., TORRES, B., BERNARDINI, L., MAGNIFICO, M.C., PAONE, A., RINALDO, S., DELLA MONICA, M., D’ARRIGO, S., POSTORIVO, D., NARDONE, A.M., ZAMPINO, G., ONESIMO, R., LEONI, C., CAICCI, F., RAIMONDO, D., BINDA, E., TROBIANI, L., DE JACO, A., TATA, A.M., FERRARI, D., CUTRUZZOLÀ, F., MAZZOCCOLI, G., ZIVIANI, E., PENNUTO, M., VESCOVI, A.L. and ROSATI, J., 2022. Retinoic acid-induced 1 gene haploinsufficiency alters lipid metabolism and causes autophagy defects in Smith-Magenis syndrome. Cell Death and Disease, 13 (11): 981. ISSN 2041-4889

VECCHIOTTI, D., VERZELLA, D., DI VITO NOLFI, M., D’ANDREA, D., FLATI, I., DI FRANCESCO, B., CORNICE, J., ALESSE, E., CAPECE, D. and ZAZZERONI, F., 2022. Elevated NF-κB/SHh/GLI1 signature denotes a worse prognosis and represent a novel potential therapeutic target in advanced prostate cancer. Cells, 11 (13): 2118. ISSN 2073-4409

This list was generated on Thu Jun 12 08:59:30 2025 UTC.